# OnCo record gortec (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gortec/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gortec" ;
  schema:name "GORTEC"@en ;
  schema:alternateName "Groupe Oncologie Radiotherapie Tete et Cou"@en, "Groupe d'Oncologie Radiothérapie Tête Et Cou"@en, "GORTEC (Groupe Oncologie Radiotherapie Tete et Cou)"@en ;
  schema:description "GORTEC is the French head and neck radiotherapy and oncology group, an association founded in 1999 that runs the academic trials behind much of the standard of care in head and neck cancer, including TPExtreme and NIVOPOSTOP in OnCo."@en ;
  schema:url <https://onco.cc/companies/gortec/>, <https://www.gortec.net> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://www.gortec.net/v/index.php/le-gortec>, <https://clinicaltrials.gov/search?lead=Groupe%20Oncologie%20Radiotherapie%20Tete%20et%20Cou> ;
  onco:tag "ctgov-sponsor", "cooperative-group" ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/> ;
  onco:trials <https://onco.cc/trials/tpextreme/>, <https://onco.cc/trials/nivopostop/> .